LifeStance CEO granted 395,683 RSUs, shares withheld for taxes

LifeStance Health Group, Inc. reported insider equity activity by its Chief Executive Officer, David Bourdon.

Accepted by SEC EDGAR 03/09/2026 - 08:11 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

LifeStance Health Group, Inc. reported insider equity activity by its Chief Executive Officer, David Bourdon. On March 5, 2026, he acquired 395,683 shares of common stock through a grant of restricted stock units, with each RSU representing the right to receive one common share.

On March 6, 2026, 65,837 shares of common stock were withheld by the company at a price of $6.93 per share to cover tax obligations from vested RSUs. The footnote explains this was a tax-withholding disposition and did not involve any open-market sale of shares.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Bourdon David

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	65,837	$6.93	$456K
Grant/Award	Common Stock	395,683	$0.00	$0.00

Holdings After Transaction: Common Stock — 1,218,085 shares (Direct)

Footnotes (2)

1. F1. Includes 395,683 restricted stock units ("RSUs") granted on March 5, 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
2. F2. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on March 6, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did LFST CEO David Bourdon report in this Form 4?

David Bourdon reported an equity award and a tax-related share withholding. He received 395,683 restricted stock units on March 5, 2026, and 65,837 shares were withheld on March 6, 2026 to satisfy tax obligations on vested RSUs, not through an open-market sale.

How many LifeStance (LFST) shares were granted to the CEO in this filing?

The CEO received 395,683 restricted stock units on March 5, 2026. Each unit represents a contingent right to one share of LifeStance’s common stock, meaning the award could translate into 395,683 shares as the RSUs vest and settle under the grant terms.

Were any LifeStance (LFST) shares sold on the open market by the CEO?

No open-market sale occurred. The 65,837 shares reported with a price of $6.93 were withheld by LifeStance on March 6, 2026 purely to cover tax withholding obligations on vested RSUs, according to the explanatory footnote.

What does the 65,837-share tax-withholding transaction mean for LFST CEO ownership?

The 65,837-share transaction reflects shares withheld to pay taxes on vested RSUs. It reduced the number of shares delivered to David Bourdon upon settlement but did not involve a market sale, so it functionally covered tax obligations rather than signaling discretionary selling.

How do the RSUs granted to the LFST CEO work according to the filing?

The filing states the CEO’s 395,683 RSUs each represent a contingent right to receive one share of common stock. These units typically convert into shares as vesting conditions are met, increasing his share ownership over time as the awards settle.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bourdon David

(Last) (First) (Middle)

C/O LIFESTANCE HEALTH GROUP, INC.

4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)

SCOTTSDALE AZ 85251

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/05/2026		A		395,683(1)	A	$0	1,283,922	D
Common Stock	03/06/2026		F(2)		65,837	D	$6.93	1,218,085	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 395,683 restricted stock units ("RSUs") granted on March 5, 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

2. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on March 6, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.

	By: /s/ Ryan Pardo, Attorney-in-Fact	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.